108 related articles for article (PubMed ID: 16824485)
1. Role of simvastatin and methyl-beta-cyclodextrin [corrected] on inhibition of poliovirus infection.
Liu S; Rodriguez AV; Tosteson MT
Biochem Biophys Res Commun; 2006 Aug; 347(1):51-9. PubMed ID: 16824485
[TBL] [Abstract][Full Text] [Related]
2. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
[TBL] [Abstract][Full Text] [Related]
3. Poliovirus infection without accumulation of eclipse particles.
Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
[TBL] [Abstract][Full Text] [Related]
4. Antipoliovirus activity and mechanism of action of 3-methylthio-5-phenyl-4-isothiazolecarbonitrile.
Garozzo A; Stivala A; Tempera G; Castro A
Antiviral Res; 2010 Dec; 88(3):325-8. PubMed ID: 20955736
[TBL] [Abstract][Full Text] [Related]
5. The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system.
Verlinden Y; Cuconati A; Wimmer E; Rombaut B
Antiviral Res; 2000 Oct; 48(1):61-9. PubMed ID: 11080541
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry.
Danthi P; Chow M
J Virol; 2004 Jan; 78(1):33-41. PubMed ID: 14671085
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of aqueous and ethanol extracts and of an isolated polysaccharide from Agaricus brasiliensis against poliovirus type 1.
Faccin LC; Benati F; Rincão VP; Mantovani MS; Soares SA; Gonzaga ML; Nozawa C; Carvalho Linhares RE
Lett Appl Microbiol; 2007 Jul; 45(1):24-8. PubMed ID: 17594456
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of poliovirus replication by an extract of Matricaria chamomilla (L)].
Vilaginès P; Delaveau P; Vilaginès R
C R Acad Sci III; 1985; 301(6):289-94. PubMed ID: 2411365
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of 3-imino-5-phenyl-3H-1,2-dithiole on poliovirus type 1 replication in vitro.
Garozzo A; Pinizzotto MR; Furneri PM; Baratta D; Guerrera F; Castro A; Tornetta B; Geremia E
Antiviral Res; 1990; 14(4-5):267-77. PubMed ID: 1965112
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of poliomyelitis: what we don't know.
Nathanson N
Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action and capsid-stabilizing properties of VHHs with an in vitro antipolioviral activity.
Schotte L; Strauss M; Thys B; Halewyck H; Filman DJ; Bostina M; Hogle JM; Rombaut B
J Virol; 2014 Apr; 88(8):4403-13. PubMed ID: 24501405
[TBL] [Abstract][Full Text] [Related]
12. Infection and direct injury in human hepatocyte explants and a hepatoblastoma cell line due to hepatiticomimetic (non-hepatitis) viruses.
Phromjai J; Aiba N; Suzuki M; Sato H; Takahara T; Kondo S; Shiraki K
J Med Virol; 2007 Apr; 79(4):413-25. PubMed ID: 17311334
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
15. 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
González ME; Almela MJ; Yacout M; Carrasco L
Antimicrob Agents Chemother; 1990 Jun; 34(6):1259-61. PubMed ID: 2168147
[TBL] [Abstract][Full Text] [Related]
16. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.
Labadie K; Saulnier A; Martin-Latil S; Colbère-Garapin F
J Virol; 2007 Mar; 81(6):3033-6. PubMed ID: 17192301
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent poliovirus for flow cytometric cell surface binding studies.
Freistadt MS; Eberle KE
J Virol Methods; 2006 Jun; 134(1-2):1-7. PubMed ID: 16600390
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment.
Gromeier M; Wetz K
J Virol; 1990 Aug; 64(8):3590-7. PubMed ID: 2164587
[TBL] [Abstract][Full Text] [Related]
19. Raft localization of CXCR4 is primarily required for X4-tropic human immunodeficiency virus type 1 infection.
Kamiyama H; Yoshii H; Tanaka Y; Sato H; Yamamoto N; Kubo Y
Virology; 2009 Mar; 386(1):23-31. PubMed ID: 19178925
[TBL] [Abstract][Full Text] [Related]
20. Entry of poliovirus into cells is blocked by valinomycin and concanamycin A.
Irurzun A; Carrasco L
Biochemistry; 2001 Mar; 40(12):3589-600. PubMed ID: 11297425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
